|
|
No coercive action against sale of available banned FDC drugs: HC
|
|
|
|
Top Stories |
|
|
|
|
SME Times News Bureau | 19 Sep, 2018
In an interim order, the Delhi High Court on Tuesday directed that no
coercive steps be taken against the sale of 328 fixed dose combination
(FDC) drugs that were banned by the government last week but are still
available in the market.
The order came on pleas filed by
different pharma companies to challenge a Ministry of Health and Family
Welfare decision to ban the manufacture, sale and distribution of these
FDC drugs with immediate effect.
Justice Vibhu Bakhru said that
the interim order would apply to companies that had moved the court and
sought the Ministry's reply. The matter was listed for September 27.
It also asked the companies to give the batch numbers of the stock available in the market.
The
petitioners included firms like Wockhardt, Glenmark, Obsurge Biotech,
Alkem Laboratories, Coral Laboratories, Mankind Pharma, Lupin, Macleods,
Laborate and Koye Pharmaceuticals.
The Ministry last week
restricted the manufacture, sale and distribution of six FDCs subject to
certain conditions, the Ministry said in a statement. The FDCs are two
or more drugs combined in a fixed ratio into a single dosage form.
The
Centre, in March 2016, had prohibited the manufacture for sale and
distribution of 349 FDCs, but it was contested by the affected
manufacturers in High Courts and the Supreme Court.
Complying
with the December 2017 Supreme Court judgment, the Drugs Technical
Advisory Board (DTAB) examined the matter and, in its report to the
Centre, recommended prohibition of the FDCs on the ground that there was
no therapeutic justification for their ingredients and that these FDCs
may involve risks to humans.
Earlier, an expert committee appointed by the Centre too had made similar observations.
Considering
the recommendations of DTAB and the expert committee, the Health
Ministry, through a gazette notification, prohibited 328 FDCs.
|
|
|
|
|
|
|
|
|
|
|
|
|
Customs Exchange Rates |
Currency |
Import |
Export |
US Dollar
|
66.20
|
64.50 |
UK Pound
|
87.50
|
84.65 |
Euro
|
78.25
|
75.65 |
Japanese
Yen |
58.85 |
56.85 |
As on 13 Aug, 2022 |
|
|
Daily Poll |
|
|
PM Modi's recent US visit to redefine India-US bilateral relations |
|
|
|
|
|
Commented Stories |
|
|
|
|
|
|
|
|